Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
-
-
-
-
-
-
-
Collegium Pharmaceutical (COLl) PT Lowered to $23 at Piper Jaffray To Reflect Removal of Onsolis From Model Estimates
-
-
-
-
-
-
-
Collegium Pharma (COLL) Prices 5M Share Stock Offering for Proceeds of $80M
-
-
-
-
-
-
-
Collegium Pharmaceutical (COLL) PT Raised to $27 at Piper Jaffray as Survey Reinforces Confidence in Xtampza ER Uptake
-
-
-
-
-
-
-
Collegium Pharmaceutical Announces Closing of Its Initial Public Offering and Exercise in Full of Option to Purchase Additional Shares
-
-
-
-
20,864 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All
